GQ1001
HER2-high solid tumors (Breast Cancer, Gastric Cancer)
Phase 1/2Active
Key Facts
Indication
HER2-high solid tumors (Breast Cancer, Gastric Cancer)
Phase
Phase 1/2
Status
Active
Company
About GeneQuantum
A global leader in ADC technology, developing next-generation bioconjugate therapeutics with proprietary enzymatic conjugation platforms.
View full company profile